The Role of ADAMTS1 and Versican in Human Myocardial Infarction: A Postmortem Study

6Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: To determine the role of a disintegrin and metalloproteinase with thrombospondin type 1 motif (ADAMTS1) and fragmented versican in the myocardial infarction (MI) process in humans and to evaluate the diagnostic efficacy of ADAMTS1 for postmortem diagnosis of MI. Methods: Thirty autopsied individuals were allocated into 2 groups, namely, a study group of individuals who died of myocardial infarction (n = 20), and a control group who died of trauma (n = 10). We performed standard immunohistochemical staining on myocardial tissue specimens, studying anti-ADAMTS1, anti-versican, and anti-versican C terminal peptide sequence (DPEAAE) fragments. Results: Strong, diffuse staining was observed throughout myocardial tissue for ADAMTS1 in the 2 groups. However, in the study group, we observed no expression for ADAMTS1 around fibrotic areas but detected slight staining in coagulative and necrotic zones. Conclusion: Similar localizations of ADAMTS and fragmented versican in human heart tissue indicate that versican presumably is cleaved by ADAMTS1. Hence, ADAMTS1 can be regarded as a new marker for postmortem differential diagnosis of MI.

Cite

CITATION STYLE

APA

Pehlivan, S., Gurses, M. S., Ural, M. N., Akyol, S., Eren, F., Turkmen Inanir, N., … Akyol, O. (2016). The Role of ADAMTS1 and Versican in Human Myocardial Infarction: A Postmortem Study. Laboratory Medicine, 47(3), 205–212. https://doi.org/10.1093/labmed/lmw022

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free